Melanoma: Immunotherapy in Advanced Melanoma and in the Adjuvant Setting
Advanced melanoma Outcome Publication (Ref) gp100 vs ipilimumab vs ipilimumab + gp100 Ipilimumab 3 mg/kg approved OS benefit Hodi et al. [18] DTIC vs DTIC + ipilimumab Ipilimumab 10 mg…